208 related articles for article (PubMed ID: 25518401)
1. [Cytokines in Kawasaki disease].
Abe J
Nihon Rinsho; 2014 Sep; 72(9):1548-53. PubMed ID: 25518401
[TBL] [Abstract][Full Text] [Related]
2. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
Ge X; Li CR; Yang J; Wang GB
Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
[TBL] [Abstract][Full Text] [Related]
3. Decreased levels of inflammatory cytokines in immunoglobulin-resistant Kawasaki disease after plasma exchange.
Fujimaru T; Ito S; Masuda H; Oana S; Kamei K; Ishiguro A; Kato H; Abe J
Cytokine; 2014 Dec; 70(2):156-60. PubMed ID: 25082649
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Wang Y; Wang W; Gong F; Fu S; Zhang Q; Hu J; Qi Y; Xie C; Zhang Y
Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
[TBL] [Abstract][Full Text] [Related]
5. Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease.
Guo MM; Tseng WN; Ko CH; Pan HM; Hsieh KS; Kuo HC
Allergy; 2015 Mar; 70(3):310-8. PubMed ID: 25585854
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
Sato S; Kawashima H; Kashiwagi Y; Hoshika A
Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
[TBL] [Abstract][Full Text] [Related]
7. Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease.
Kuo HC; Wang CL; Liang CD; Yu HR; Huang CF; Wang L; Hwang KP; Yang KD
Pediatr Allergy Immunol; 2009 May; 20(3):266-72. PubMed ID: 19438983
[TBL] [Abstract][Full Text] [Related]
8. [Regulation of proinflammatory cytokine cascade in Kawasaki disease].
Furukawa S; Matsubara T; Ichiyama T
Nihon Rinsho; 2008 Feb; 66(2):258-64. PubMed ID: 18260323
[TBL] [Abstract][Full Text] [Related]
9. Infliximab reduces the cytokine-mediated inflammation but does not suppress cellular infiltration of the vessel wall in refractory Kawasaki disease.
Hirono K; Kemmotsu Y; Wittkowski H; Foell D; Saito K; Ibuki K; Watanabe K; Watanabe S; Uese K; Kanegane H; Origasa H; Ichida F; Roth J; Miyawaki T; Saji T
Pediatr Res; 2009 Jun; 65(6):696-701. PubMed ID: 19430379
[TBL] [Abstract][Full Text] [Related]
10. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
Hu P; Jiang GM; Wu Y; Huang BY; Liu SY; Zhang DD; Xu Y; Wu YF; Xia X; Wei W; Hu B
Clin Chim Acta; 2017 Aug; 471():76-80. PubMed ID: 28526535
[TBL] [Abstract][Full Text] [Related]
11. Management of acute and refractory Kawasaki disease.
Tacke CE; Burgner D; Kuipers IM; Kuijpers TW
Expert Rev Anti Infect Ther; 2012 Oct; 10(10):1203-15. PubMed ID: 23199405
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory cytokine profiles during Cyclosporin treatment for immunoglobulin-resistant Kawasaki disease.
Hamada H; Suzuki H; Abe J; Suzuki Y; Suenaga T; Takeuchi T; Yoshikawa N; Shibuta S; Miyawaki M; Oishi K; Yamaga H; Aoyagi N; Iwahashi S; Miyashita R; Honda T; Onouchi Y; Terai M; Hata A
Cytokine; 2012 Dec; 60(3):681-5. PubMed ID: 22944461
[TBL] [Abstract][Full Text] [Related]
13. Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment.
Gupta M; Noel GJ; Schaefer M; Friedman D; Bussel J; Johann-Liang R
J Clin Immunol; 2001 May; 21(3):193-9. PubMed ID: 11403226
[TBL] [Abstract][Full Text] [Related]
14. Monocyte-Derived Interleukin-1β As the Driver of S100A12-Induced Sterile Inflammatory Activation of Human Coronary Artery Endothelial Cells: Implications for the Pathogenesis of Kawasaki Disease.
Armaroli G; Verweyen E; Pretzer C; Kessel K; Hirono K; Ichida F; Okabe M; Cabral DA; Foell D; Brown KL; Kessel C
Arthritis Rheumatol; 2019 May; 71(5):792-804. PubMed ID: 30447136
[TBL] [Abstract][Full Text] [Related]
15. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y
Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of Th17 cells and the related cytokines with treatment in Kawasaki disease.
Rasouli M; Heidari B; Kalani M
Immunol Lett; 2014 Nov; 162(1 Pt A):269-75. PubMed ID: 25277751
[TBL] [Abstract][Full Text] [Related]
17. Response of refractory Kawasaki disease to intravenous methylprednisolone.
Shah I; Prabhu SS
Ann Trop Paediatr; 2009 Mar; 29(1):51-3. PubMed ID: 19222935
[TBL] [Abstract][Full Text] [Related]
18. Infliximab as a novel therapy for refractory Kawasaki disease.
Weiss JE; Eberhard BA; Chowdhury D; Gottlieb BS
J Rheumatol; 2004 Apr; 31(4):808-10. PubMed ID: 15088313
[TBL] [Abstract][Full Text] [Related]
19. Do cytokines correlate with refractory Kawasaki disease in children?
Wang Y; Qian SY; Yuan Y; Wang Q; Gao L; Chen X; Yu X; Zhen Z
Clin Chim Acta; 2020 Jul; 506():222-227. PubMed ID: 32156603
[TBL] [Abstract][Full Text] [Related]
20. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition.
Li Y; Zheng Q; Zou L; Wu J; Guo L; Teng L; Zheng R; Jung LKL; Lu M
Pediatr Rheumatol Online J; 2019 Jan; 17(1):1. PubMed ID: 30611297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
